Optiver Holding’s Humana HUM Stock Holding History

Optiver Holding’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-125	Closed	-$49K	–	685
2021 Q4	$49K	Hold	125	–	–	﹤0.01%	428
2021 Q3	$49K	Buy	+125	New	+$53.1K	﹤0.01%	338

Other funds holding HUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Optiver Holding's HUM Position: Q1 2022 in Review

Optiver Holding sold out of Humana (HUM) in Q1 2022, closing a stake of 125 shares — an estimated $49K sold.

Optiver Holding first reported a position in HUM in Q3 2021 and held it in 2 quarters. The position peaked at $49K in Q4 2021. 914 funds tracked by Wall St. Rank hold HUM as of Q1 2022.

Optiver Holding reported no remaining Humana position as of Q1 2022 after selling out during the quarter.
Optiver Holding sold 125 Humana shares in Q1 2022, an estimated $49K.
Optiver Holding first reported a position in Humana in Q3 2021 and held it in 2 quarters.
Optiver Holding's Humana position peaked at $49K in Q4 2021.
914 funds tracked by Wall St. Rank held Humana as of Q1 2022.

Based on Optiver Holding's 13F filing for Q1 2022, filed 16 May 2022.